Cargando…

FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer

Identification of noncoding drivers from thousands of somatic alterations in a typical tumor is a difficult and unsolved problem. We report a computational framework, FunSeq2, to annotate and prioritize these mutations. The framework combines an adjustable data context integrating large-scale genomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Yao, Liu, Zhu, Lou, Shaoke, Bedford, Jason, Mu, Xinmeng Jasmine, Yip, Kevin Y, Khurana, Ekta, Gerstein, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203974/
https://www.ncbi.nlm.nih.gov/pubmed/25273974
http://dx.doi.org/10.1186/s13059-014-0480-5
_version_ 1782340476322447360
author Fu, Yao
Liu, Zhu
Lou, Shaoke
Bedford, Jason
Mu, Xinmeng Jasmine
Yip, Kevin Y
Khurana, Ekta
Gerstein, Mark
author_facet Fu, Yao
Liu, Zhu
Lou, Shaoke
Bedford, Jason
Mu, Xinmeng Jasmine
Yip, Kevin Y
Khurana, Ekta
Gerstein, Mark
author_sort Fu, Yao
collection PubMed
description Identification of noncoding drivers from thousands of somatic alterations in a typical tumor is a difficult and unsolved problem. We report a computational framework, FunSeq2, to annotate and prioritize these mutations. The framework combines an adjustable data context integrating large-scale genomics and cancer resources with a streamlined variant-prioritization pipeline. The pipeline has a weighted scoring system combining: inter- and intra-species conservation; loss- and gain-of-function events for transcription-factor binding; enhancer-gene linkages and network centrality; and per-element recurrence across samples. We further highlight putative drivers with information specific to a particular sample, such as differential expression. FunSeq2 is available from funseq2.gersteinlab.org. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13059-014-0480-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4203974
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42039742014-10-23 FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer Fu, Yao Liu, Zhu Lou, Shaoke Bedford, Jason Mu, Xinmeng Jasmine Yip, Kevin Y Khurana, Ekta Gerstein, Mark Genome Biol Method Identification of noncoding drivers from thousands of somatic alterations in a typical tumor is a difficult and unsolved problem. We report a computational framework, FunSeq2, to annotate and prioritize these mutations. The framework combines an adjustable data context integrating large-scale genomics and cancer resources with a streamlined variant-prioritization pipeline. The pipeline has a weighted scoring system combining: inter- and intra-species conservation; loss- and gain-of-function events for transcription-factor binding; enhancer-gene linkages and network centrality; and per-element recurrence across samples. We further highlight putative drivers with information specific to a particular sample, such as differential expression. FunSeq2 is available from funseq2.gersteinlab.org. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13059-014-0480-5) contains supplementary material, which is available to authorized users. BioMed Central 2014-10-02 2014 /pmc/articles/PMC4203974/ /pubmed/25273974 http://dx.doi.org/10.1186/s13059-014-0480-5 Text en © Fu et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Method
Fu, Yao
Liu, Zhu
Lou, Shaoke
Bedford, Jason
Mu, Xinmeng Jasmine
Yip, Kevin Y
Khurana, Ekta
Gerstein, Mark
FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer
title FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer
title_full FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer
title_fullStr FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer
title_full_unstemmed FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer
title_short FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer
title_sort funseq2: a framework for prioritizing noncoding regulatory variants in cancer
topic Method
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203974/
https://www.ncbi.nlm.nih.gov/pubmed/25273974
http://dx.doi.org/10.1186/s13059-014-0480-5
work_keys_str_mv AT fuyao funseq2aframeworkforprioritizingnoncodingregulatoryvariantsincancer
AT liuzhu funseq2aframeworkforprioritizingnoncodingregulatoryvariantsincancer
AT loushaoke funseq2aframeworkforprioritizingnoncodingregulatoryvariantsincancer
AT bedfordjason funseq2aframeworkforprioritizingnoncodingregulatoryvariantsincancer
AT muxinmengjasmine funseq2aframeworkforprioritizingnoncodingregulatoryvariantsincancer
AT yipkeviny funseq2aframeworkforprioritizingnoncodingregulatoryvariantsincancer
AT khuranaekta funseq2aframeworkforprioritizingnoncodingregulatoryvariantsincancer
AT gersteinmark funseq2aframeworkforprioritizingnoncodingregulatoryvariantsincancer